Title:
がんを処置するためのクローディン１８．２に対する抗体を伴う併用療法
Document Type and Number:
Japanese Patent JP7204791
Kind Code:
B2
Abstract:
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
Inventors:
Ughur Shahin
Utzlem Thulec
Rita Mitt Nacht-Klaus
Stephan Dennis Jacobs
Magdalena Yadwiga Ush
Cornelia Adriana Maria Heinz
Christiane Regina Stadler
Utzlem Thulec
Rita Mitt Nacht-Klaus
Stephan Dennis Jacobs
Magdalena Yadwiga Ush
Cornelia Adriana Maria Heinz
Christiane Regina Stadler
Application Number:
JP2021015688A
Publication Date:
January 16, 2023
Filing Date:
February 03, 2021
Export Citation:
Assignee:
Astellas Pharma Inc.
International Classes:
A61K39/395; A61K31/282; A61K31/337; A61K31/4745; A61K31/513; A61K31/519; A61K31/704; A61K33/243; A61P35/00; A61P43/00
Domestic Patent References:
| JP6833885B2 | ||||
| JP6490764B2 | ||||
| JP6203831B2 |
Attorney, Agent or Firm:
Murayama Yasuhiko
Shinya Mihiro
Tatsuhiko Abe
Shinya Mihiro
Tatsuhiko Abe
Previous Patent: Data protection inquiry interface
Next Patent: WI-FI hotspot connection method and terminal
Next Patent: WI-FI hotspot connection method and terminal